GlaxoSmithKline S.A.E. (BIOC) EPS
EPS
EGP 0.4075
Diluted EPS, fiscal year 2018
Earnings per share (EPS) is net income divided by the number of shares outstanding — the profit attributable to each share. Figures on this page are diluted EPS, in Egyptian pounds per share.
EPS history
| Fiscal year | EPS (diluted) |
|---|---|
| 2018 | 0.4075 |
| 2017 | 1.2255 |
| 2016 | -0.05 |
| 2015 | 0.83 |
| 2014 | 0.77 |
| 2013 | 0.92 |
| 2012 | 0.86 |
| 2011 | 1.01 |
Figures are diluted EPS, in EGP per share.
All monetary figures in EGP. Source: Egyptian Exchange via TradingView; annual figures from company disclosures; updated weekly. Prices refresh every 15 minutes during EGX trading hours.